MENU
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines designed for patients suffering from debilitating immunological diseases with significant unmet medical need.
At Kiniksa, we put patients at the center of everything we do. Our goal is to advance therapies for patients suffering from debilitating immunological diseases with significant unmet medical need. We are also committed to understanding and supporting the broader needs of the patient communities. Hear Nadine's story of living with recurrent pericarditis.
A diagnosis of pericarditis can come with many questions. Whether you’re experiencing your first flare or suffering from recurrent episodes, WhatIsPericarditis.com may help uncover the answers you have been looking for.
Develop and commercialize a pipeline of product candidates with validated mechanisms of action, strong biologic rationale, and offer the potential for differentiation.
We are relentless and focused on putting patients at the center of everything we do and strive to develop life-changing medicines.
